Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder

Detalhes bibliográficos
Autor(a) principal: Turan,Turgay
Data de Publicação: 2018
Outros Autores: Efiloğlu,Özgür, Günaydin,Bilal, Özkanli,Şeyma, Nikerel,Emrah, Atiş,Gökhan, Çaşkurlu,Turhan, Yildirim,Asif
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000200267
Resumo: ABSTRACT Objective To evaluate the prognostic value of the depth of lamina propria invasion in patients with T1 bladder cancer and to display comparative differences between the T1a/b and T1e/m substaging systems. Patients and Methods This study included 106 patients with primary stage T1 urothelial bladder tumours who underwent surgery between January 2009 and December 2014. Pathologic specimens were re-evaluated to confirm the diagnosis of T1 and substaging by the same pathologist using two systems: T1a and T1b, and T1m and T1e. Age, tumour size, multiplicity, associated carcinoma in situ, tumour grade, and T1 substaging system were investigated to detect the relation between disease progression and recurrence. Results The recurrence rate was 52% for T1a (n=42) vs. 76% for T1b (n=20) (p=0.028) and 55% for T1m (n=32) vs. 62% for T1e (n=30), respectively (p=0.446). There was no significant difference between the substaging groups for disease progression: T1a (n=12, 15%) vs. T1b (n=7, 27%), and T1m (n=8, 13.8%) vs. T1e (n=11, 23%) (p>0.05). In the multivariate analysis, tumour size >3 cm (p=0.008), multiplicity (p=0.049), and substaging T1b (p=0.043) were independent predictive factors for tumour recurrence. According to the Kaplan-Meier actuarial method, recurrence-free survival was significantly different in patients with pT1a tumours compared with those with pT1b tumours (p=0.033). Conclusions Substaging T1 provides a prediction of disease recurrence. Regarding recurrence, T1a/b substaging can provide better knowledge of disease behaviour because it is predicted as more superior than T1 m/e, and it can help in determining the requirement for early cystectomy.
id SBU-1_c5b0305aca9a3badce704a49d9f97a25
oai_identifier_str oai:scielo:S1677-55382018000200267
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladderCarcinomaUrinary BladderUrinary Bladder NeoplasmsABSTRACT Objective To evaluate the prognostic value of the depth of lamina propria invasion in patients with T1 bladder cancer and to display comparative differences between the T1a/b and T1e/m substaging systems. Patients and Methods This study included 106 patients with primary stage T1 urothelial bladder tumours who underwent surgery between January 2009 and December 2014. Pathologic specimens were re-evaluated to confirm the diagnosis of T1 and substaging by the same pathologist using two systems: T1a and T1b, and T1m and T1e. Age, tumour size, multiplicity, associated carcinoma in situ, tumour grade, and T1 substaging system were investigated to detect the relation between disease progression and recurrence. Results The recurrence rate was 52% for T1a (n=42) vs. 76% for T1b (n=20) (p=0.028) and 55% for T1m (n=32) vs. 62% for T1e (n=30), respectively (p=0.446). There was no significant difference between the substaging groups for disease progression: T1a (n=12, 15%) vs. T1b (n=7, 27%), and T1m (n=8, 13.8%) vs. T1e (n=11, 23%) (p>0.05). In the multivariate analysis, tumour size >3 cm (p=0.008), multiplicity (p=0.049), and substaging T1b (p=0.043) were independent predictive factors for tumour recurrence. According to the Kaplan-Meier actuarial method, recurrence-free survival was significantly different in patients with pT1a tumours compared with those with pT1b tumours (p=0.033). Conclusions Substaging T1 provides a prediction of disease recurrence. Regarding recurrence, T1a/b substaging can provide better knowledge of disease behaviour because it is predicted as more superior than T1 m/e, and it can help in determining the requirement for early cystectomy.Sociedade Brasileira de Urologia2018-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000200267International braz j urol v.44 n.2 2018reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/s1677-5538.ibju.2017.0424info:eu-repo/semantics/openAccessTuran,TurgayEfiloğlu,ÖzgürGünaydin,BilalÖzkanli,ŞeymaNikerel,EmrahAtiş,GökhanÇaşkurlu,TurhanYildirim,Asifeng2018-04-17T00:00:00Zoai:scielo:S1677-55382018000200267Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2018-04-17T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
title Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
spellingShingle Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
Turan,Turgay
Carcinoma
Urinary Bladder
Urinary Bladder Neoplasms
title_short Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
title_full Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
title_fullStr Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
title_full_unstemmed Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
title_sort Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
author Turan,Turgay
author_facet Turan,Turgay
Efiloğlu,Özgür
Günaydin,Bilal
Özkanli,Şeyma
Nikerel,Emrah
Atiş,Gökhan
Çaşkurlu,Turhan
Yildirim,Asif
author_role author
author2 Efiloğlu,Özgür
Günaydin,Bilal
Özkanli,Şeyma
Nikerel,Emrah
Atiş,Gökhan
Çaşkurlu,Turhan
Yildirim,Asif
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Turan,Turgay
Efiloğlu,Özgür
Günaydin,Bilal
Özkanli,Şeyma
Nikerel,Emrah
Atiş,Gökhan
Çaşkurlu,Turhan
Yildirim,Asif
dc.subject.por.fl_str_mv Carcinoma
Urinary Bladder
Urinary Bladder Neoplasms
topic Carcinoma
Urinary Bladder
Urinary Bladder Neoplasms
description ABSTRACT Objective To evaluate the prognostic value of the depth of lamina propria invasion in patients with T1 bladder cancer and to display comparative differences between the T1a/b and T1e/m substaging systems. Patients and Methods This study included 106 patients with primary stage T1 urothelial bladder tumours who underwent surgery between January 2009 and December 2014. Pathologic specimens were re-evaluated to confirm the diagnosis of T1 and substaging by the same pathologist using two systems: T1a and T1b, and T1m and T1e. Age, tumour size, multiplicity, associated carcinoma in situ, tumour grade, and T1 substaging system were investigated to detect the relation between disease progression and recurrence. Results The recurrence rate was 52% for T1a (n=42) vs. 76% for T1b (n=20) (p=0.028) and 55% for T1m (n=32) vs. 62% for T1e (n=30), respectively (p=0.446). There was no significant difference between the substaging groups for disease progression: T1a (n=12, 15%) vs. T1b (n=7, 27%), and T1m (n=8, 13.8%) vs. T1e (n=11, 23%) (p>0.05). In the multivariate analysis, tumour size >3 cm (p=0.008), multiplicity (p=0.049), and substaging T1b (p=0.043) were independent predictive factors for tumour recurrence. According to the Kaplan-Meier actuarial method, recurrence-free survival was significantly different in patients with pT1a tumours compared with those with pT1b tumours (p=0.033). Conclusions Substaging T1 provides a prediction of disease recurrence. Regarding recurrence, T1a/b substaging can provide better knowledge of disease behaviour because it is predicted as more superior than T1 m/e, and it can help in determining the requirement for early cystectomy.
publishDate 2018
dc.date.none.fl_str_mv 2018-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000200267
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000200267
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1677-5538.ibju.2017.0424
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.44 n.2 2018
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318075923660800